Organon
Generated by Meeveem AI
"Women's health treatments, biosimilars and established medicines across multiple therapeutic areas"
About Organon
Organon is a global pharmaceutical company headquartered in Jersey City, New Jersey, focused on improving women’s health. Its portfolio spans contraception and fertility treatments, biosimilars and established medicines for conditions including cardiovascular and respiratory disease and bone health. It supplies healthcare professionals and health systems across a range of therapeutic areas.
The brand traces its origins to the Netherlands in 1923; the current company separated from Merck in 2021. In 2025, it reported more than 70 medicines and products and distribution to over 140 countries and territories. Its UK team is based in London, with a manufacturing facility in Cramlington, Northumberland.
A connected manufacturing network
Organon operates six manufacturing facilities across Europe, Latin America and Asia. Its sites and supporting functions work with external contractors, suppliers and partners in an integrated global network. Operational, technology and procurement specialists also support its external manufacturing network.
Employee voice
The company has ten Employee Resource Groups, each open to all employees. It also gathers feedback through annual surveys and regular check-ins covering engagement, wellbeing, inclusion and its organisational values.
10188
Team Members
1923
Founded
Pharma
Sector
Hybrid
Work Environment